Research study Program year 2024 Source: CMS Open Payments

Phase Iia

Research payments

$883,391

111 payments

Through program year 2024, $883,391 in research payments was reported against Phase Iia, across 111 payments, paid by Genentech, Inc..

Paid by: Genentech, Inc.
ClinicalTrials.gov: No trial number was reported for this study

By program year

3 rows

Year	Kind	Amount	Payments
2024	Research	$401,541	51
2023	Research	$438,291	51
2022	Research	$43,558	9

Breakdown

Who paid Research payments · program years 2022–2024

Genentech, Inc. $883,391 111 payments

Who received the money Research payments · program years 2022–2024

Pharmaceutical Research And Consulting INC Organisation paid for research $192,004 14 payments
Mayo Clinic - Rochester Organisation paid for research $141,279 11 payments
Southern California Institute Organisation paid for research $112,699 8 payments
Pioneer Clinical Studies Organisation paid for research $107,107 15 payments
Clinical Research Associates Of Central PA LLC Organisation paid for research $85,374 18 payments
California Medical Research Associates INC Organisation paid for research $71,991 3 payments
Adac Research PA Organisation paid for research $59,528 7 payments
Institute For The Advancement Of Clinical Trials LLC Organisation paid for research $35,687 11 payments
Bellingham Asthma Allergy And Immunology Clinic Organisation paid for research $32,250 12 payments
Midwest Clinical Research LLC Organisation paid for research $25,819 8 payments

Usually the institution or organisation running the study, not a person.

Records

Every payment, record by record

Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.

Principal investigators named

7 shown

Named on the study's payments. Being named is not being paid: the money in the figures above went to the recipients listed, not necessarily to these people.

What you are looking at

Research payments are tied to a study. Being named on a study as a principal investigator is reported separately from being paid as a recipient, and the two are not the same thing — a named investigator has not necessarily received the money.